Carregant...
The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury
BACKGROUND: RRx-001, a clinical macrophage-stimulating anti-cancer agent that also produces nitric oxide (NO) was studied in a model of ischemia-reperfusion injury. METHODS: The production of NO is dependent on the oxygen tension because nitric oxide synthases convert l-arginine to NO and l-citrulli...
Guardat en:
| Publicat a: | Expert Rev Hematol |
|---|---|
| Autors principals: | , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8051333/ https://ncbi.nlm.nih.gov/pubmed/28448172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17474086.2017.1324779 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|